Back to top
more

QIAGEN (QGEN)

(Delayed Data from NYSE)

$36.95 USD

36.95
1,964,098

+0.37 (1.01%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $36.96 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

QIAGEN Releases Coronavirus Test Kit in US on New FDA Policy

by Zacks Equity Research

QIAGEN (QGEN) releases test kits in the United States to speed up the diagnosis of coronavirus per the FDA's latest policy.

    Zacks Equity Research

    Here's Why You Should Add Hill-Rom Stock to Your Portfolio

    by Zacks Equity Research

    Investors continue to be optimistic about Hill-Rom (HRC) on its strong domestic and international results in the first quarter of fiscal 2020.

    Zacks Equity Research

    The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

    Zacks Equity Research

    Coronavirus Test Kit Demand to Drive These 3 Stocks

    by Zacks Equity Research

    Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

    Zacks Equity Research

    Top Ranked Momentum Stocks to Buy for March 20th

    by Zacks Equity Research

    Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 20th

    Debanjana Dey headshot

    4 MedTech Stocks to Scoop Up Amid the Coronavirus Crisis

    by Debanjana Dey

    Here are some MedTech stocks that are expected to provide some respite to investors amid the turmoil.

    Zacks Equity Research

    QIAGEN Gets CE Nod for QIAstat-Dx Respiratory SARS-CoV-2 Test

    by Zacks Equity Research

    The regulatory clearance of this test has made QIAGEN (QGEN) a key player in coronavirus diagnosis.

    Urmimala Biswas headshot

    3 Medical Stocks Poised to Trounce Market on Coronavirus Scare

    by Urmimala Biswas

    Here are three Medical stocks showing early signs of stellar growth, banking on the choppy global market scenario.

    Zacks Equity Research

    Is QIAGEN N.V. (QGEN) Outperforming Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (QGEN) Outperforming Other Medical Stocks This Year?

    Zacks Equity Research

    BD (BDX) & BioGX Submit EUA to Speed Up Coronavirus Screening

    by Zacks Equity Research

    BD (BDX) expects screening to ramp up by 1,000 per day once authorized.